The pipeline, honestly staged
Programme, indication, modality and stage, presented consistently and updated when it moves. This is the first thing an investor or partner looks for and the thing most often out of date on biotech sites.
San Francisco
Biotech websites in San Francisco four audiences, one careful site.
A biotech site is read by scientists, investors, partners and candidates, and the language that impresses one of them frequently loses another.
Overview
What a life sciences site has to carry
Biotech website design in San Francisco costs $10,000 to $50,000. The difficulty is audience rather than design: scientists want the mechanism and the publications, investors want the pipeline and the milestones, partners want the platform, and candidates want the team. One site has to serve all four without diluting any of them.
The platform explained twice
Once for a scientist, once for someone who is not one. The mechanism, why it is differentiated and what it enables. Companies that only write the technical version lose the investor; only the plain version loses the scientist.
Publications and data
Peer reviewed work, preprints, posters and presentations, linked and current. In this field the publication list is the credibility, and a page that stops in 2023 says something you did not intend.
Careful claims
What a company may say about a therapeutic candidate is governed, and the constraints tighten as programmes advance. Your regulatory and legal advisors define what is permissible; we build the site so the required language sits where it belongs.
Careers against everyone
You are hiring scientists against companies with far larger budgets. Science, the team, publications and how the group works do measurable recruiting work that a job listing does not.
Built for updates by your team
Pipeline stages, publications, team changes and news move constantly. If each change is an agency ticket, the site lags reality, which is exactly the impression a biotech company cannot afford to give.
Pricing
What a Bay Area biotech site costs
| Project | Range (USD) | Timeline | What you get |
|---|---|---|---|
| Early stage company | $10,000 to $20,000 | 6 to 10 weeks | Home, platform, pipeline, team, publications, careers, editable system |
| Clinical stage company | $20,000 to $35,000 | 10 to 18 weeks | Above plus programme pages, investor section, news, deeper scientific content |
| Larger or public company | $35,000 to $70,000 | 16 to 28 weeks | Multi-audience structure, investor relations, compliance workflow, migration |
| Pipeline and publications system | $4,000 to $12,000 | 2 to 6 weeks | Structured content your team updates without a developer |
| Care plan | $400 to $2,500 per month | Ongoing | Updates, publications, pipeline changes, monitoring |
The number moves with how many audiences the site serves and how much review each page has to pass, not with page count.
Detail
What to ask before you sign
| Ask them | A good answer sounds like | Walk away if |
|---|---|---|
| What does this actually cost? | A range, and what moves it, before a call | You must book a call to learn the ballpark |
| Who owns the code and design files? | You do, unconditionally, in the contract | Ownership depends on staying on a retainer |
| Can I see Core Web Vitals on three live sites? | URLs, and an honest word about the slowest | They show you portfolio shots |
| Who maintains it after launch? | A named arrangement and response time | Not discussed until it breaks |
An agency that will not put these in writing has answered the question anyway.
Comparison
Where biotech sites fail their readers
| Reader | What goes wrong |
|---|---|
| Scientist | Marketing language with no mechanism or data |
| Investor | A pipeline that has not been updated since the last raise |
| Partner | No clear account of what the platform enables |
| Candidate | A careers page with listings and nothing about the science |
| Regulator or counsel | Claims that outran what the data supports |
| Journalist | No contact, no assets, no plain description of the company |
FAQ
Common questions
How much does a biotech website cost in San Francisco?
An early stage company runs $10,000 to $20,000. A clinical stage company with programme and investor sections runs $20,000 to $35,000. Larger and public companies run $35,000 to $70,000.
How do we serve scientists and investors on the same site?
By writing the platform twice: once with the mechanism and data, once in plain language with the commercial case. Distinct paths from the homepage rather than one averaged narrative that satisfies neither reader.
What about claims regulation?
What a company may say about a therapeutic candidate is governed and the constraints tighten as programmes advance. Your regulatory and legal advisors define what is permissible and we build the site so required language sits where it belongs.
How should the pipeline be presented?
Programme, indication, modality and stage, in a consistent structure your team can update the day something moves. An out of date pipeline is the most damaging thing on a biotech site and the most common.
Do publications matter on the website?
They are the credibility. Peer reviewed work, preprints, posters and presentations, linked and current. A publications page that stops two years ago tells a reader something about the company you did not intend to say.
Can the site help with hiring?
Considerably. You are competing for scientists against much larger budgets, and the science, the team and how the group works do more recruiting than a job listing. It is frequently among the most visited sections.
Can our team update it?
It has to be. Pipeline stages, publications, team changes and news move constantly, and a site that lags reality gives exactly the impression a life sciences company cannot afford.
Do you have an office in San Francisco?
No. We work with Bay Area companies remotely on overlapping Pacific hours and would rather say that than imply otherwise. Not carrying Bay Area overheads is part of the cost difference.
Next step
Tell us what you need.
Send us what you are trying to fix and we will tell you what it takes, what it costs, and whether we are the right people for it. If we are not, we will say so.